Company: ABBV
Filing Date: 2025-10-31
Form Type: 8-K
Source: 0001551152-25-000047
Chunk: 1

Company: AbbVie Inc.
Filing Date: 2025-10-31
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits

  Exhibit No.      Exhibit                                                                                                  
  99.1             Press Release dated October 31, 2025 (furnished pursuant to Item 2.02).                                  
  104              The cover page from this Current Report on Form 8-K formatted in Inline XBRL (included as Exhibit 101).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  ABBVIE INC.                
  /s/ Scott T. Reents        
  Scott T. Reents            
  Executive Vice President,  
  Chief Financial Officer